0001437749-22-013131.txt : 20220519 0001437749-22-013131.hdr.sgml : 20220519 20220519204243 ACCESSION NUMBER: 0001437749-22-013131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220517 FILED AS OF DATE: 20220519 DATE AS OF CHANGE: 20220519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furcht Leo CENTRAL INDEX KEY: 0001775749 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38207 FILM NUMBER: 22945011 MAIL ADDRESS: STREET 1: C/O CELCUITY, 16305 36TH AVENUE N. STREET 2: #100 CITY: MINNEAPOLIS STATE: MN ZIP: 55445 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celcuity Inc. CENTRAL INDEX KEY: 0001603454 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 BUSINESS PHONE: 763-392-0767 MAIL ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 FORMER COMPANY: FORMER CONFORMED NAME: Celcuity LLC DATE OF NAME CHANGE: 20140324 4 1 rdgdoc.xml FORM 4 X0306 4 2022-05-17 0001603454 Celcuity Inc. CELC 0001775749 Furcht Leo 16305 36TH AVENUE NORTH SUITE 100 MINNEAPOLIS MN 55446 1 Stock Option (right to buy) 1.6000 2022-12-14 Common Stock 250 250 D Stock Option (right to buy) 1.6000 2023-12-14 Common Stock 250 250 D Stock Option (right to buy) 3.6000 2024-12-14 Common Stock 250 250 D Stock Option (right to buy) 7.6000 2025-12-14 Common Stock 250 250 D Stock Option (right to buy) 7.6000 2026-12-14 Common Stock 250 250 D Stock Option (right to buy) 18.95 2022-05-17 4 D 0 500 D 2027-12-29 Common Stock 500 0 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 500 A 2027-12-29 Common Stock 500 500 D Stock Option (right to buy) 23.99 2022-05-17 4 D 0 500 D 2028-12-31 Common Stock 500 0 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 500 A 2028-12-31 Common Stock 500 500 D Stock Option (right to buy) 22.45 2022-05-17 4 D 0 5054 D 2029-05-16 Common Stock 5054 0 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 5054 A 2029-05-16 Common Stock 5054 5054 D Stock Option (right to buy) 5.1000 2030-05-14 Common Stock 25308 25308 D Stock Option (right to buy) 26.99 2022-05-17 4 D 0 4619 D 2031-05-12 Common Stock 4619 0 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 4619 A 2031-05-12 Common Stock 4619 4619 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 24449 0 A 2032-05-17 Common Stock 24449 24449 D Fully vested. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. /s/ Eric O. Madson as Attorney-in-Fact for Leo Furcht pursuant to Power of Attorney previously filed. 2022-05-19